Tapewire

Nasdaq · USD

BLFS

BIOLIFE SOLUTIONS INC

Export transactions ↓
Tapewire entity
4614
SEC CIK
0000834365
Parsed reports
1,001

Last 12 months

Inside the activity.

0 purchase rows · 39 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 2025014
Dec 202508
Jan 202605
Feb 202600
Mar 202609
Apr 202600
May 202603
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
July 19, 2023 Filed Jul 24, 2023 20:35 UTC
Mathew Aby J.EVP & Chief Scientific Officer
Exercise / conversionCommon Stock 10,000 $2.06 $20,600.00
Disclosure

SEC source: 0001628280-23-025476 · wk-form4_1690230904.xml · nonDerivative · entry 1

Mathew Aby J. · CIK 0001556355 · EVP & Chief Scientific Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 281,919

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
July 11, 2023 Filed Jul 13, 2023 21:10 UTC
Schulz MarcusChief Revenue Officer
SaleCommon Stock 331 $22.79 $7,543.49
Disclosure

SEC source: 0001628280-23-024862 · wk-form4_1689282625.xml · nonDerivative · entry 1

Schulz Marcus · CIK 0001812702 · Chief Revenue Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 43,231

F1 · kind: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 10-07-2019 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.

Read SEC document
June 27, 2023 Filed Jun 29, 2023 20:40 UTC
Rice MichaelDirector · Chief Executive Officer
SaleCommon Stock 877 $22.91 $20,092.07
Disclosure

SEC source: 0001628280-23-023916 · wk-form4_1688071205.xml · nonDerivative · entry 1

Rice Michael · CIK 0001389512 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 418,912

F1 · kind: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 03-25-2020 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.

Read SEC document
June 27, 2023 Filed Jun 29, 2023 20:38 UTC
Mathew Aby J.EVP & Chief Scientific Officer
SaleCommon Stock 695 $22.91 $15,922.45
Disclosure

SEC source: 0001628280-23-023914 · wk-form4_1688071092.xml · nonDerivative · entry 1

Mathew Aby J. · CIK 0001556355 · EVP & Chief Scientific Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 271,919

F1 · kind: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 03-25-2020 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.

Read SEC document
June 27, 2023 Filed Jun 29, 2023 20:37 UTC
Foster Karen A.Chief Quality Officer
SaleCommon Stock 590 $22.91 $13,516.90
Disclosure

SEC source: 0001628280-23-023912 · wk-form4_1688071012.xml · nonDerivative · entry 1

Foster Karen A. · CIK 0001683151 · Chief Quality Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 124,908

F1 · kind: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 03-25-2020 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.

Read SEC document
June 27, 2023 Filed Jun 29, 2023 20:35 UTC
Berard ToddChief Marketing Officer
SaleCommon Stock 489 $22.91 $11,202.99
Disclosure

SEC source: 0001628280-23-023910 · wk-form4_1688070930.xml · nonDerivative · entry 1

Berard Todd · CIK 0001633186 · Chief Marketing Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 118,959

F1 · kind: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 03-25-2020 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.

Read SEC document
June 22, 2023 Filed Jun 23, 2023 20:58 UTC
Mathew Aby J.EVP & Chief Scientific Officer
Exercise / conversionEmployee Stock Option · Derivative 10,000 $0.00 Strike: $2.06 $0.00
Disclosure

SEC source: 0001628280-23-023339 · wk-form4_1687553889.xml · derivative · entry 6

Mathew Aby J. · CIK 0001556355 · EVP & Chief Scientific Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 70,000

Underlying: Common Stock · 10,000 shares

Expires 2025-05-04

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: On May 4, 2015, the reporting person was granted an option to purchase 229,837 shares of common stock which vested 25% on the first anniversary of the grant date, and in 36 equal monthly installments thereafter.

Read SEC document
June 22, 2023 Filed Jun 23, 2023 20:58 UTC
Mathew Aby J.EVP & Chief Scientific Officer
SaleCommon Stock 10,000 $23.32 $233,200.00
Disclosure

SEC source: 0001628280-23-023339 · wk-form4_1687553889.xml · nonDerivative · entry 4

Mathew Aby J. · CIK 0001556355 · EVP & Chief Scientific Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 272,614

F1 · kind: The sales reported were effected pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 11-15-2022.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.10 to $23.42, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
June 22, 2023 Filed Jun 23, 2023 20:58 UTC
Mathew Aby J.EVP & Chief Scientific Officer
Exercise / conversionCommon Stock 10,000 $2.06 $20,600.00
Disclosure

SEC source: 0001628280-23-023339 · wk-form4_1687553889.xml · nonDerivative · entry 3

Mathew Aby J. · CIK 0001556355 · EVP & Chief Scientific Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 282,614

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
June 22, 2023 Filed Jun 26, 2023 20:36 UTC
Wichterman TroyChief Financial Officer
SaleCommon Stock 541 $23.41 $12,664.81
Disclosure

SEC source: 0001628280-23-023458 · wk-form4_1687811752.xml · nonDerivative · entry 1

Wichterman Troy · CIK 0001892616 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 66,612

F1 · kind: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 06-19-2020 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.

Read SEC document
June 21, 2023 Filed Jun 23, 2023 20:58 UTC
Mathew Aby J.EVP & Chief Scientific Officer
Exercise / conversionEmployee Stock Option · Derivative 10,000 $0.00 Strike: $2.06 $0.00
Disclosure

SEC source: 0001628280-23-023339 · wk-form4_1687553889.xml · derivative · entry 5

Mathew Aby J. · CIK 0001556355 · EVP & Chief Scientific Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 80,000

Underlying: Common Stock · 10,000 shares

Expires 2025-05-04

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: On May 4, 2015, the reporting person was granted an option to purchase 229,837 shares of common stock which vested 25% on the first anniversary of the grant date, and in 36 equal monthly installments thereafter.

Read SEC document
June 21, 2023 Filed Jun 23, 2023 20:58 UTC
Mathew Aby J.EVP & Chief Scientific Officer
SaleCommon Stock 10,000 $22.97 $229,700.00
Disclosure

SEC source: 0001628280-23-023339 · wk-form4_1687553889.xml · nonDerivative · entry 2

Mathew Aby J. · CIK 0001556355 · EVP & Chief Scientific Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 272,614

F1 · kind: The sales reported were effected pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 11-15-2022.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.51 to $23.23, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
June 21, 2023 Filed Jun 23, 2023 20:58 UTC
Mathew Aby J.EVP & Chief Scientific Officer
Exercise / conversionCommon Stock 10,000 $2.06 $20,600.00
Disclosure

SEC source: 0001628280-23-023339 · wk-form4_1687553889.xml · nonDerivative · entry 1

Mathew Aby J. · CIK 0001556355 · EVP & Chief Scientific Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 282,614

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 31, 2023 Filed Jun 3, 2023 00:02 UTC
Mathew Aby J.EVP & Chief Scientific Officer
SaleCommon Stock 504 $23.21 $11,697.84
Disclosure

SEC source: 0001437749-23-016547 · rdgdoc.xml · nonDerivative · entry 1

Mathew Aby J. · CIK 0001556355 · EVP & Chief Scientific Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 272,614

F1 · kind: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 02-24-2022 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.

Read SEC document
May 31, 2023 Filed Jun 3, 2023 00:01 UTC
Berard ToddChief Marketing Officer
SaleCommon Stock 337 $23.21 $7,821.77
Disclosure

SEC source: 0001437749-23-016546 · rdgdoc.xml · nonDerivative · entry 1

Berard Todd · CIK 0001633186 · Chief Marketing Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 119,448

F1 · kind: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 02-24-2022 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.

Read SEC document
May 31, 2023 Filed Jun 3, 2023 00:01 UTC
Wichterman TroyChief Financial Officer
SaleCommon Stock 560 $23.21 $12,997.60
Disclosure

SEC source: 0001437749-23-016545 · rdgdoc.xml · nonDerivative · entry 1

Wichterman Troy · CIK 0001892616 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 67,153

F1 · kind: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 02-24-2022 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.

Read SEC document
May 31, 2023 Filed Jun 3, 2023 00:01 UTC
Schulz MarcusChief Revenue Officer
SaleCommon Stock 337 $23.21 $7,821.77
Disclosure

SEC source: 0001437749-23-016544 · rdgdoc.xml · nonDerivative · entry 1

Schulz Marcus · CIK 0001812702 · Chief Revenue Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 43,562

F1 · kind: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 02-24-2022 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.

Read SEC document
May 31, 2023 Filed Jun 3, 2023 00:00 UTC
Aebersold SarahChief Human Resources Officer
SaleCommon Stock 337 $23.21 $7,821.77
Disclosure

SEC source: 0001437749-23-016543 · rdgdoc.xml · nonDerivative · entry 1

Aebersold Sarah · CIK 0001837756 · Chief Human Resources Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 44,445

F1 · kind: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 02-24-2022 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.

Read SEC document
May 31, 2023 Filed Jun 3, 2023 00:00 UTC
Rice MichaelDirector · CEO
SaleCommon Stock 1,679 $23.21 $38,969.59
Disclosure

SEC source: 0001437749-23-016542 · rdgdoc.xml · nonDerivative · entry 1

Rice Michael · CIK 0001389512 · Director · CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 419,789

F1 · kind: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 02-24-2022 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.

Read SEC document
May 31, 2023 Filed Jun 3, 2023 00:00 UTC
Foster Karen A.Chief Quality Officer
SaleCommon Stock 392 $23.21 $9,098.32
Disclosure

SEC source: 0001437749-23-016541 · rdgdoc.xml · nonDerivative · entry 1

Foster Karen A. · CIK 0001683151 · Chief Quality Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 125,498

F1 · kind: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 02-24-2022 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.

Read SEC document
May 31, 2023 Filed Jun 23, 2023 23:30 UTC
Phillips GeraintSVP, Global Operations
SaleCommon Stock 174 $23.21 $4,038.54
Disclosure

SEC source: 0001437749-23-018319 · rdgdoc.xml · nonDerivative · entry 1

Phillips Geraint · CIK 0001960665 · SVP, Global Operations

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 58,333

F1 · kind: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 02-24-2022 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.

Read SEC document
May 25, 2023 Filed May 26, 2023 00:18 UTC
Mathew Aby J.EVP & Chief Scientific Officer
Exercise / conversionEmployee Stock Option · Derivative 10,000 $0.00 Strike: $2.06 $0.00
Disclosure

SEC source: 0001437749-23-015899 · rdgdoc.xml · derivative · entry 6

Mathew Aby J. · CIK 0001556355 · EVP & Chief Scientific Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 90,000

Underlying: Common Stock · 10,000 shares

Expires 2025-05-04

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: On May 4, 2015, the reporting person was granted an option to purchase 229,837 shares of common stock which vested 25% on the first anniversary of the grant date, and in 36 equal monthly installments thereafter.

Read SEC document
May 25, 2023 Filed May 26, 2023 00:18 UTC
Mathew Aby J.EVP & Chief Scientific Officer
SaleCommon Stock 10,000 $22.33 $223,300.00
Disclosure

SEC source: 0001437749-23-015899 · rdgdoc.xml · nonDerivative · entry 4

Mathew Aby J. · CIK 0001556355 · EVP & Chief Scientific Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 273,118

F1 · kind: The sales reported were effected pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 11-15-2022.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.15 to $22.45, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
May 25, 2023 Filed May 26, 2023 00:18 UTC
Mathew Aby J.EVP & Chief Scientific Officer
Exercise / conversionCommon Stock 10,000 $2.06 $20,600.00
Disclosure

SEC source: 0001437749-23-015899 · rdgdoc.xml · nonDerivative · entry 3

Mathew Aby J. · CIK 0001556355 · EVP & Chief Scientific Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 283,118

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 24, 2023 Filed May 26, 2023 00:18 UTC
Mathew Aby J.EVP & Chief Scientific Officer
Exercise / conversionEmployee Stock Option · Derivative 10,000 $0.00 Strike: $2.06 $0.00
Disclosure

SEC source: 0001437749-23-015899 · rdgdoc.xml · derivative · entry 5

Mathew Aby J. · CIK 0001556355 · EVP & Chief Scientific Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 100,000

Underlying: Common Stock · 10,000 shares

Expires 2025-05-04

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: On May 4, 2015, the reporting person was granted an option to purchase 229,837 shares of common stock which vested 25% on the first anniversary of the grant date, and in 36 equal monthly installments thereafter.

Read SEC document
May 24, 2023 Filed May 26, 2023 00:18 UTC
Mathew Aby J.EVP & Chief Scientific Officer
SaleCommon Stock 10,000 $22.14 $221,400.00
Disclosure

SEC source: 0001437749-23-015899 · rdgdoc.xml · nonDerivative · entry 2

Mathew Aby J. · CIK 0001556355 · EVP & Chief Scientific Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 273,118

F1 · kind: The sales reported were effected pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 11-15-2022.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.72 to $22.34, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
May 24, 2023 Filed May 26, 2023 00:18 UTC
Mathew Aby J.EVP & Chief Scientific Officer
Exercise / conversionCommon Stock 10,000 $2.06 $20,600.00
Disclosure

SEC source: 0001437749-23-015899 · rdgdoc.xml · nonDerivative · entry 1

Mathew Aby J. · CIK 0001556355 · EVP & Chief Scientific Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 283,118

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 22, 2023 Filed May 23, 2023 21:46 UTC
Casdin Eli10% owner
PurchaseCommon Stock, par value $.001 per share 24,973 $21.86 $545,789.91
Disclosure

SEC source: 0000919574-23-003449 · ownership.xml · nonDerivative · entry 2

Casdin Partners Master Fund, L.P. · CIK 0001534265 · 10% owner

Casdin Capital, LLC · CIK 0001534261 · 10% owner

Casdin Partners GP, LLC · CIK 0001534260 · 10% owner

Casdin Eli · CIK 0001534264 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 150,000

F2 · ownership.nature: The securities are owned directly by a client of Casdin Capital, LLC ("Casdin Capital") and may be deemed to be indirectly beneficially owned by (i) Casdin Capital, the investment adviser to such client; (ii) Casdin Partners GP, LLC ("Casdin GP"), the general partner of such client, and (iii) Eli Casdin, the managing member of Casdin Capital and Casdin GP.

Read SEC document
May 19, 2023 Filed May 23, 2023 21:46 UTC
Casdin Eli10% owner
PurchaseCommon Stock, par value $.001 per share 50,000 $22.55 $1,127,430.00
Disclosure

SEC source: 0000919574-23-003449 · ownership.xml · nonDerivative · entry 1

Casdin Partners Master Fund, L.P. · CIK 0001534265 · 10% owner

Casdin Capital, LLC · CIK 0001534261 · 10% owner

Casdin Partners GP, LLC · CIK 0001534260 · 10% owner

Casdin Eli · CIK 0001534264 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 125,027

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions within the range of $22.07753 to $23.0197. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

F2 · ownership.nature: The securities are owned directly by a client of Casdin Capital, LLC ("Casdin Capital") and may be deemed to be indirectly beneficially owned by (i) Casdin Capital, the investment adviser to such client; (ii) Casdin Partners GP, LLC ("Casdin GP"), the general partner of such client, and (iii) Eli Casdin, the managing member of Casdin Capital and Casdin GP.

Read SEC document
May 18, 2023 Filed May 19, 2023 00:31 UTC
Casdin Eli10% owner
PurchaseCommon Stock, par value $.001 per share 30,000 $21.76 $652,692.00
Disclosure

SEC source: 0000919574-23-003408 · ownership.xml · nonDerivative · entry 3

Casdin Partners Master Fund, L.P. · CIK 0001534265 · 10% owner

Casdin Capital, LLC · CIK 0001534261 · 10% owner

Casdin Partners GP, LLC · CIK 0001534260 · 10% owner

Casdin Eli · CIK 0001534264 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 75,027

F2 · ownership.nature: The securities are owned directly by a client of Casdin Capital, LLC ("Casdin Capital") and may be deemed to be indirectly beneficially owned by (i) Casdin Capital, the investment adviser to such client; (ii) Casdin Partners GP, LLC ("Casdin GP"), the general partner of such client, and (iii) Eli Casdin, the managing member of Casdin Capital and Casdin GP.

Read SEC document
May 17, 2023 Filed May 18, 2023 01:52 UTC
Rice MichaelDirector · CEO
SaleCommon Stock 33,333 $21.04 $701,326.32
Disclosure

SEC source: 0001437749-23-015004 · rdgdoc.xml · nonDerivative · entry 2

Rice Michael · CIK 0001389512 · Director · CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 421,468

F2 · kind: The sales reported were effected pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 09-14-2022.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.00 to $21.18, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
May 17, 2023 Filed May 19, 2023 00:31 UTC
Casdin Eli10% owner
PurchaseCommon Stock, par value $.001 per share 30,027 $21.30 $639,445.98
Disclosure

SEC source: 0000919574-23-003408 · ownership.xml · nonDerivative · entry 2

Casdin Partners Master Fund, L.P. · CIK 0001534265 · 10% owner

Casdin Capital, LLC · CIK 0001534261 · 10% owner

Casdin Partners GP, LLC · CIK 0001534260 · 10% owner

Casdin Eli · CIK 0001534264 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 45,027

F3 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions within the range of $20.98 to $21.8582. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

F2 · ownership.nature: The securities are owned directly by a client of Casdin Capital, LLC ("Casdin Capital") and may be deemed to be indirectly beneficially owned by (i) Casdin Capital, the investment adviser to such client; (ii) Casdin Partners GP, LLC ("Casdin GP"), the general partner of such client, and (iii) Eli Casdin, the managing member of Casdin Capital and Casdin GP.

Read SEC document
May 16, 2023 Filed May 18, 2023 01:51 UTC
Wichterman TroyChief Financial Officer
SaleCommon Stock 137 $19.41 $2,659.17
Disclosure

SEC source: 0001437749-23-015001 · rdgdoc.xml · nonDerivative · entry 1

Wichterman Troy · CIK 0001892616 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 67,713

F1 · kind: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 08-09-2021 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.

Read SEC document
May 16, 2023 Filed May 19, 2023 00:31 UTC
Casdin Eli10% owner
PurchaseCommon Stock, par value $.001 per share 15,000 $20.19 $302,835.00
Disclosure

SEC source: 0000919574-23-003408 · ownership.xml · nonDerivative · entry 1

Casdin Partners Master Fund, L.P. · CIK 0001534265 · 10% owner

Casdin Capital, LLC · CIK 0001534261 · 10% owner

Casdin Partners GP, LLC · CIK 0001534260 · 10% owner

Casdin Eli · CIK 0001534264 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 15,000

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions within the range of $20.1643 to $20.2385. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

F2 · ownership.nature: The securities are owned directly by a client of Casdin Capital, LLC ("Casdin Capital") and may be deemed to be indirectly beneficially owned by (i) Casdin Capital, the investment adviser to such client; (ii) Casdin Partners GP, LLC ("Casdin GP"), the general partner of such client, and (iii) Eli Casdin, the managing member of Casdin Capital and Casdin GP.

Read SEC document
May 16, 2023 Filed Jun 23, 2023 23:31 UTC
Phillips GeraintSVP, Global Operations
SaleCommon Stock 100 $19.41 $1,941.00
Disclosure

SEC source: 0001437749-23-018320 · rdgdoc.xml · nonDerivative · entry 1

Phillips Geraint · CIK 0001960665 · SVP, Global Operations

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 58,507

F1 · kind: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 08-09-2021 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.

Read SEC document
May 15, 2023 Filed May 18, 2023 01:53 UTC
Mathew Aby J.EVP & Chief Scientific Officer
SaleCommon Stock 125 $18.71 $2,338.75
Disclosure

SEC source: 0001437749-23-015007 · rdgdoc.xml · nonDerivative · entry 1

Mathew Aby J. · CIK 0001556355 · EVP & Chief Scientific Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 273,118

F1 · kind: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 02-08-2021 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.

Read SEC document
May 15, 2023 Filed May 18, 2023 01:53 UTC
Foster Karen A.Chief Quality Officer
SaleCommon Stock 106 $18.71 $1,983.26
Disclosure

SEC source: 0001437749-23-015006 · rdgdoc.xml · nonDerivative · entry 1

Foster Karen A. · CIK 0001683151 · Chief Quality Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 125,890

F1 · kind: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 02-08-2021 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.

Read SEC document
May 15, 2023 Filed May 18, 2023 01:53 UTC
Schulz MarcusChief Revenue Officer
SaleCommon Stock 75 $18.71 $1,403.25
Disclosure

SEC source: 0001437749-23-015005 · rdgdoc.xml · nonDerivative · entry 1

Schulz Marcus · CIK 0001812702 · Chief Revenue Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 43,899

F1 · kind: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 02-08-2021 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.

Read SEC document
May 15, 2023 Filed May 18, 2023 01:52 UTC
Aebersold SarahChief Human Resources Officer
SaleCommon Stock 72 $18.71 $1,347.12
Disclosure

SEC source: 0001437749-23-015003 · rdgdoc.xml · nonDerivative · entry 1

Aebersold Sarah · CIK 0001837756 · Chief Human Resources Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 44,782

F1 · kind: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 02-08-2021 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.

Read SEC document
May 15, 2023 Filed May 18, 2023 01:52 UTC
Rice MichaelDirector · CEO
SaleCommon Stock 190 $18.71 $3,554.90
Disclosure

SEC source: 0001437749-23-015004 · rdgdoc.xml · nonDerivative · entry 1

Rice Michael · CIK 0001389512 · Director · CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 454,801

F1 · kind: The sale reported herein was made to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock granted on February 8, 2021.

Read SEC document
May 15, 2023 Filed May 18, 2023 01:52 UTC
Berard ToddChief Marketing Officer
SaleCommon Stock 92 $18.71 $1,721.32
Disclosure

SEC source: 0001437749-23-015002 · rdgdoc.xml · nonDerivative · entry 1

Berard Todd · CIK 0001633186 · Chief Marketing Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 119,785

F1 · kind: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 02-08-2021 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.

Read SEC document
April 20, 2023 Filed Apr 21, 2023 23:00 UTC
Mathew Aby J.EVP & Chief Scientific Officer
Exercise / conversionEmployee Stock Option · Derivative 10,000 $0.00 Strike: $2.06 $0.00
Disclosure

SEC source: 0001437749-23-010843 · rdgdoc.xml · derivative · entry 6

Mathew Aby J. · CIK 0001556355 · EVP & Chief Scientific Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 110,000

Underlying: Common Stock · 10,000 shares

Expires 2025-05-04

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: On May 4, 2015, the reporting person was granted an option to purchase 229,837 shares of common stock which vested 25% on the first anniversary of the grant date, and in 36 equal monthly installments thereafter.

Read SEC document
April 20, 2023 Filed Apr 21, 2023 23:00 UTC
Mathew Aby J.EVP & Chief Scientific Officer
SaleCommon Stock 10,000 $19.25 $192,500.00
Disclosure

SEC source: 0001437749-23-010843 · rdgdoc.xml · nonDerivative · entry 4

Mathew Aby J. · CIK 0001556355 · EVP & Chief Scientific Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 268,352

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 11-15-2022

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.15 to $19.50, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
April 20, 2023 Filed Apr 21, 2023 23:00 UTC
Mathew Aby J.EVP & Chief Scientific Officer
Exercise / conversionCommon Stock 10,000 $2.06 $20,600.00
Disclosure

SEC source: 0001437749-23-010843 · rdgdoc.xml · nonDerivative · entry 3

Mathew Aby J. · CIK 0001556355 · EVP & Chief Scientific Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 278,352

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
April 19, 2023 Filed Apr 21, 2023 23:00 UTC
Mathew Aby J.EVP & Chief Scientific Officer
Exercise / conversionEmployee Stock Option · Derivative 10,000 $0.00 Strike: $2.06 $0.00
Disclosure

SEC source: 0001437749-23-010843 · rdgdoc.xml · derivative · entry 5

Mathew Aby J. · CIK 0001556355 · EVP & Chief Scientific Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 120,000

Underlying: Common Stock · 10,000 shares

Expires 2025-05-04

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: On May 4, 2015, the reporting person was granted an option to purchase 229,837 shares of common stock which vested 25% on the first anniversary of the grant date, and in 36 equal monthly installments thereafter.

Read SEC document
April 19, 2023 Filed Apr 21, 2023 23:00 UTC
Mathew Aby J.EVP & Chief Scientific Officer
SaleCommon Stock 10,000 $19.47 $194,700.00
Disclosure

SEC source: 0001437749-23-010843 · rdgdoc.xml · nonDerivative · entry 2

Mathew Aby J. · CIK 0001556355 · EVP & Chief Scientific Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 268,352

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 11-15-2022

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.31 to $19.57, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
April 19, 2023 Filed Apr 21, 2023 23:00 UTC
Mathew Aby J.EVP & Chief Scientific Officer
Exercise / conversionCommon Stock 10,000 $2.06 $20,600.00
Disclosure

SEC source: 0001437749-23-010843 · rdgdoc.xml · nonDerivative · entry 1

Mathew Aby J. · CIK 0001556355 · EVP & Chief Scientific Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 278,352

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
April 19, 2023 Filed Apr 21, 2023 23:00 UTC
Schulz MarcusChief Revenue Officer
SaleCommon Stock 430 $19.33 $8,311.90
Disclosure

SEC source: 0001437749-23-010842 · rdgdoc.xml · nonDerivative · entry 1

Schulz Marcus · CIK 0001812702 · Chief Revenue Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 41,062

F1 · kind: The sale reported herein was made to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.

F2 · kind: Adoption date of referenced 10b5-1(c) plan is: 7/17/2020

Read SEC document
April 19, 2023 Filed Apr 21, 2023 23:00 UTC
Aebersold SarahChief Human Resources Officer
SaleCommon Stock 292 $19.33 $5,644.36
Disclosure

SEC source: 0001437749-23-010841 · rdgdoc.xml · nonDerivative · entry 1

Aebersold Sarah · CIK 0001837756 · Chief Human Resources Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 42,059

F1 · kind: The sale reported herein was made to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.

F2 · kind: Adoption date of referenced 10b5-1(c) plan is: 7/17/2020

Read SEC document
April 14, 2023 Filed Apr 18, 2023 23:28 UTC
Schulz MarcusChief Revenue Officer
SaleCommon Stock 215 $21.05 $4,525.75
Disclosure

SEC source: 0001437749-23-010569 · primary_doc.xml · nonDerivative · entry 1

Schulz Marcus · CIK 0001812702 · Chief Revenue Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 41,492

F1 · kind: The sale reported herein was made to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.